CDC statement on increased lead absorption in young children, establishing early screening and intervention guidance.

CDC guidelines on childhood lead poisoning prevention, updating screening thresholds and intervention recommendations.

Revised CDC guidelines for preventing childhood lead poisoning, lowering the blood lead level of concern and broadening screening criteria.

American Academy of Pediatrics policy statement on childhood lead poisoning, addressing screening, diagnosis, and treatment recommendations.

ATSDR report to Congress documenting the scope of childhood lead poisoning in the United States and recommending federal action.

The 1991 ACCLPP strategic plan outlining a national framework for eliminating childhood lead poisoning through prevention, screening, and policy.

The October 1991 ACCLPP statement lowering the blood lead level of concern to 10 µg/dL and recommending universal screening for young children.

Illinois state guidelines adapting the 1991 federal CDC framework to clinical practice: screening criteria, diagnostic workup, medical management, and community intervention. Produced by the Illinois Childhood Lead Poisoning Prevention Program.

AAP committee report evaluating whether universal blood lead screening recommendations should be revised in light of declining prevalence.

Texas state guidelines for physicians and health care providers on screening, diagnosing, and managing childhood lead poisoning, contemporaneous with the TLC trial enrollment period.

AAP clinical guidelines for the treatment of lead exposure in children, including chelation therapy thresholds and management protocols.

AAP Committee on Environmental Health policy statement updating screening recommendations for elevated blood lead levels in children.

ACCLPP recommendations for the management of elevated blood lead levels in young children, including clinical and environmental interventions.

ACCLPP guidance on housing-focused primary prevention strategies for reducing lead exposure in children before poisoning occurs.

ACCLPP report on using geographic information systems to target and improve childhood lead poisoning prevention efforts.

ACCLPP guidance on preventing childhood lead poisoning, including screening recommendations and intervention thresholds.

ACCLPP report on strategies for protecting children from lead-based paint hazards through primary prevention and housing policy.

AAP clinical report on the prevention, detection, and management of lead exposure in children, updating pediatric practice recommendations.

ACCLPP recommendations on interpreting and managing blood lead levels below the then-current level of concern of 10 µg/dL.

ACCLPP summary report recommending elimination of the 10 µg/dL level of concern and adoption of a reference value based on population data.

CDC's official response to the 2012 ACCLPP recommendations, adopting the blood lead reference value and updating national guidance.

AAP policy statement on preventing childhood lead toxicity, endorsing the CDC reference value and calling for stronger regulatory and public health action.

USPSTF updated evidence report and systematic review on screening asymptomatic children and pregnant women for elevated blood lead levels, published in JAMA.

AHRQ Evidence Synthesis No. 174 — the underlying systematic review supporting the USPSTF recommendation statement. More detailed than the JAMA publication.